Showing 791-800 of 23043 results for "".
Optimizing Monitoring after Ide-cel in RRMM: What the Evidence Shows
https://reachmd.com/programs/Audioabstracts/monitoring-ide-cel-rrmm/48730/This is a non-certified educational series produced and controlled by ReachMD. As CAR T-cell therapy becomes more widely used in multiple myeloma, understanding when toxicities occur is critical to balancing safety and access. Hear from Dr. Mimi Maeusli as she reviews new clinical and real-world finA Global View of Oncofertility: Lessons Learned from Around the World
https://reachmd.com/programs/project-oncology/a-global-view-of-oncofertility-lessons-learned-from-around-the-world/13141/What can we learn from oncofertility services and efforts from other countries around the world?AMOR-IPAT: A New Idea to Reduce the Rate of Cesarean Section
https://reachmd.com/programs/advances-in-womens-health/amor-ipat-a-new-idea-to-reduce-the-rate-of-cesarean-section/3661/Over the last decade the rate of cesarean sections has increased from 22 percent to as much as 30 percent in some parts of the country. Cesarean risk increases with potential placental insufficiency and concerns about cephalo pelvic disproportion. How does AMOR-IPAT (active management of risk in preReprogamming Skin Cells to Act Like Stem Cells
https://reachmd.com/programs/clinicians-roundtable/reprogamming-skin-cells-to-act-like-stem-cells/2588/Dr. Johnathan Moreno speaks with host Dr. Maurie Pickard about this year’s ground breaking research in the reprogramming of skin cells to act like stem cells. They also discuss the need for new embryonic cell lines that continue to be the gold standard. Continued progress in this area of research, hBoston Legal's Christian Clemenson on Aspergers II
https://reachmd.com/programs/clinicians-roundtable/boston-legals-christian-clemenson-on-aspergers-ii/1977/Can an actor teach us how to better undertand our patients? Christian Clemenson, who plays Jerry "Hands" Espenson on Boston Legal discusses his role as a chacter with Aspergers Syndrome with host Dr. Bill Rutenberg.Next Horizons in Specialty Leadership: Dr. Tom Gellhaus, President-Elect of ACOG
https://reachmd.com/programs/advances-in-womens-health/next-horizons-specialty-leadership-dr-tom-gellhaus-president-elect-acog/7488/Dr. Matt Birnholz welcomes Dr. Tom Gellhaus, President-Elect of The American College of Obstetricians and Gynecologists, to discuss his vision for ACOG's initiatives to come, inspired in part by both his unique clinical training background and his extensive legislative activity experience on behalfHIV Prevention in LGBT Adolescents: A New Center's Innovative Approach
https://reachmd.com/programs/clinicians-roundtable/hiv-prevention-in-lgbt-adolescents-a-new-centers-innovative-approach/7057/The Gender, Sexuality and HIV Prevention Center at Ann & Robert H Lurie Children's Hospital of Chicago is the first of its kind facilty for adolescent patients. Host Dr. Jennifer Caudle welcoms the center's director, Dr. Robert Garofalo. Dr. Garofalo will share the center's mission of supportinThe American Health Care Paradox: Why Spending More is Getting Us Less
https://reachmd.com/programs/conversations-on-health-care/the-american-health-care-paradox-why-spending-more-is-getting-us-less/6985/This week, Mark and Margaret speak with Dr. Elizabeth Bradley, Director of or the Yale Global Health Initiative and Faculty Director of the Global Health Leadership Institute. Dr. Bradley is author of The American Health Care Paradox: Why Spending More is Getting Us Less, which examines reasons forThe Most Common Pediatric Cancer: Acute Lymphoblastic Leukemia
https://reachmd.com/programs/focus-on-childrens-health/the-most-common-pediatric-cancer-acute-lymphoblastic-leukemia/5713/What is the presentation of pediatric patients with acute lymphoblastic leukemia, and how old are these children? What factors help determine the prognosis for a child? Dr. Stephen Hunger, section head of pediatric oncology and hematology, oncology and bone marrow transplantation, at the UniversityAdvances in Follicular Lymphoma Treatment: CAR T-Cell Therapy’s Evolving Role
https://reachmd.com/programs/project-oncology/advances-in-follicular-lymphoma-treatment-car-t-cell-therapys-evolving-role/35485/This is a non-certified educational series produced and controlled by ReachMD. As the therapeutic landscape for follicular lymphoma continues to evolve, CAR T-cell therapy is emerging as a transformative option for select patients with relapsed or high-risk disease. But it also comes with a lot of i